AMS announces that a collaborative research project with the National Cancer Center Hospital (Japan) has been accepted for presentation at the SNMMI 2026 Annual Meeting, to be held in Los Angeles, USA, from May 30 to June 2, 2026.

The accepted abstract, titled “Initial Performance Evaluation of a Novel Automated System for ¹⁷⁷Lu Removal from Patient Urine Post-Radionuclide Therapy,” reports the initial performance evaluation of a novel automated system designed to remove ¹⁷⁷Lu (Lutetium-177) from patient urine following radionuclide therapy.

This research was conducted as a collaboration between National Cancer Center Hospital and AMS.